Navigation Links
Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
Date:7/22/2008

A Pilot Study Suggests That Ekkyo's New Approach of LASH (Laser Assisted

Scar Healing) can Drastically Improve Scar Healing Physiology

MARSEILLES, France, July 22 /PRNewswire/ -- Ekkyo (formerly known as Heatwave Technology) a photomedicine company, which develops first-in-class laser-based systems for skin scar prevention and reduction, announced today the publication of a scientific article in Lasers in Surgery and Medicine* reporting the results of a pilot study on cutaneous scar prevention by LASH.

Based on the therapeutic effects of controlled selective hyperthermia, Ekkyo's approach aims to stimulate the natural repair mechanisms of the skin, initiated at the critical moment of wound closure (ie the thrombotic phase). This innovative approach was validated in animals by a proof of concept study performed using an 810 nm laser diode system that showed its ability to speed up the healing process and avoid visible marks of the wounds (Capon, Souil et al. 2001 Lasers Surg Med. 2001;28(2):168-75).

To demonstrate the relevance of this approach in humans, a pilot** clinical trial, focused on abdominoplasty, was carried out at the Lille University Hospital Center (in September 2006 - December 2007). Conducted by Dr. Alexandre Capon, plastic surgeon, the aim of the study was twofold: evaluating the safety, as well as the therapeutic and cosmetic benefits of a treatment by an 810 nm laser diode. This is the base for the handheld laser Ekkylite(TM) the very first Laser Assisted Scar Healing system using a "smart" safety device in charge of recognizing, setting up and defining the parameters of the laser during treatment.

"The results of this study are very encouraging; they validate our approach from the view point of safety and efficacy in a difficult clinical context of abdominal plasty that usually leaves unsightly long scars ; they impact patients self esteem and decrease the benefits of the surgical intervention," comments Dr. Gwenaelle Iarmarcovai, head of Ekkyo's Clinical trials.

"This article confirms the benefits of the LASH technology to speed up the healing process and dramatically reduce or even prevent scars," said Alain Cornil, company CEO and co-founder. "We are now ready to launch EkkyLite(TM), our first laser system, which should soon become the reference for surgeons and their patients undergoing surgeries," he added.

**About the Clinical Pilot Study - Protocol no 0631

The clinical pilot study included 5 female patients with Fitzpatrick skin types I-IV with linear surgical scars of greater than 2 cm. The main objective of the trial was to evaluate safety and performance of the 810 nm laser diode system.

Each surgical incision was randomly divided in two parts ; 8 cm receiving an 810 nm laser diode treatment. The other part was not being treated. Patients were treated with doses ranging between 80 and 120 J/cm2.

Scar appearance was evaluated for inflammation, thickness, width, discretion and linearity by surgeon and patient at 10 days, 3 months, and 12 months.

The final scar analysis at 12 months after laser treatment showed that the treated portion of the scar is of better quality as measured by the surgeon and the patient relative to untreated scar parts. No significant complications occurred during or after the course of this study.

About Ekkyo

Created in 2006 by one specialist in photomedicine, one plastic surgeon, one marketing expert specialized in medical devices and one specialist in production and quality processes, EKKYO formerly known as Heatwave Technology is a photomedicine company that develops first-in-class laser-based systems for scar prevention and reduction.

Resulting mostly from the pioneering work of Ekkyo's founding scientists and clinicians, Ekkylite(TM) is the first company's product. This very first Laser Assisted Scar Healing system combines a handheld laser, a "smart" safety device that guides the surgeon's moves during the laser treatment and a sterile sheath for working in the operating room. EkkyLite(TM) activates and stimulates the skin regeneration process resulting in faster healing, while preventing, reducing and sometimes completely erasing surgical scars.

The therapeutic, aesthetic and practical benefits provided by EkkyLite(TM) makes it the first laser technology accessible to all surgeons: not only plastic surgeons but also specialists experiencing scarring issues such as dermatologists, obstetricians, trauma specialists...

Currently in clinical phase, the commercialization of the Ekkylite(TM) system is forecasted for 2008 in France and for 2009 successively in Europe and the United States. Based in Meyreuil, France, Ekkyo has 8 staff members as of December 2007.

More on http://www.ekkyo.com

*Alexandre C. Capon et al. LSM-08-0066 (20657)

Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology. The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties.


'/>"/>
SOURCE EKKYO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Cell Publication Describes the Novel Kinase Regulators Using OriGenes Functional Kinome Collection
2. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
3. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
6. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
9. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
10. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... 23, 2017 Regulus Therapeutics Inc . ... development of innovative medicines targeting microRNAs, today announced it ... results on Thursday, March 2, 2017 after the market ... and webcast on March 2, 2017 at 5:00 p.m. ... 2016 financial results and provide a general business update.  ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... The California State University Institute for Palliative Care ... or interested in palliative care education and research. The Symposium, “Innovate. Investigate. Educate: ... San Diego on Sept. 28 and 29, 2017, on the campus of California State ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... 2017 , ... The Radiology Business Management Association will select the ... annual Building Better Radiology Marketing Programs conference, held this year from March ... Nine awards are given out in five categories. They are:, , ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the ... The Jensie Gran Fondo of Marin. For the second year in a row, ... mineral-based sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to ...
Breaking Medicine News(10 mins):